Literature DB >> 28321951

Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies.

Gabriel Santpere1,2, Paula Garcia-Esparcia3, Pol Andres-Benito3, Belen Lorente-Galdos1,2, Arcadi Navarro2,4,5,6, Isidro Ferrer3,7,8,9.   

Abstract

The present study investigates global transcriptional changes in frontal cortex area 8 in incidental Lewy Body disease (iLBD), Parkinson disease (PD) and Dementia with Lewy bodies (DLB). We identified different coexpressed gene sets associated with disease stages, and gene ontology categories enriched in gene modules and differentially expressed genes including modules or gene clusters correlated to iLBD comprising upregulated dynein genes and taste receptors, and downregulated innate inflammation. Focusing on DLB, we found modules with genes significantly enriched in functions related to RNA and DNA production, mitochondria and energy metabolism, purine metabolism, chaperone and protein folding system and synapses and neurotransmission (particularly the GABAergic system). The expression of more than fifty selected genes was assessed with real time quantitative polymerase chain reaction. Our findings provide, for the first time, evidence of molecular cortical alterations in iLBD and involvement of several key metabolic pathways and gene hubs in DLB which may underlie cognitive impairment and dementia.
© 2017 International Society of Neuropathology.

Entities:  

Keywords:  GABA; Lewy body diseases; axonema; cerebral cortex; chaperones; dementia with Lewy bodies; dynein; mitochondria; neurotransmission; purine metabolism; synapses; taste receptors; transcriptome

Mesh:

Year:  2017        PMID: 28321951     DOI: 10.1111/bpa.12511

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  13 in total

1.  The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of α-synuclein.

Authors:  Rachel Underwood; Bing Wang; Christine Carico; Robert H Whitaker; William J Placzek; Talene A Yacoubian
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

Review 2.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

3.  Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo.

Authors:  Rachel E Lackie; Aline S de Miranda; Mei Peng Lim; Vladislav Novikov; Nimrod Madrer; Nadun C Karunatilleke; Benjamin S Rutledge; Stephanie Tullo; Anne Brickenden; Matthew E R Maitland; David Greenberg; Daniel Gallino; Wen Luo; Anoosha Attaran; Irina Shlaifer; Esther Del Cid Pellitero; Caroline Schild-Poulter; Thomas M Durcan; Edward A Fon; Martin Duennwald; Flavio H Beraldo; M Mallar Chakravarty; Timothy J Bussey; Lisa M Saksida; Hermona Soreq; Wing-Yiu Choy; Vania F Prado; Marco A M Prado
Journal:  Acta Neuropathol       Date:  2022-09-19       Impact factor: 15.887

4.  An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias.

Authors:  Arnab Datta; Yuek Ling Chai; Jing Min Tan; Jasinda H Lee; Paul T Francis; Christopher P Chen; Siu Kwan Sze; Mitchell K P Lai
Journal:  Mol Brain       Date:  2017-08-11       Impact factor: 4.041

5.  HSP90 and Its Novel Co-Chaperones, SGT1 and CHP-1, in Brain of Patients with Parkinson's Disease and Dementia with Lewy Bodies.

Authors:  Anastasiia Bohush; Grażyna Niewiadomska; Serge Weis; Anna Filipek
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

Review 6.  Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson's Disease.

Authors:  Ane Murueta-Goyena; Ane Andikoetxea; Juan Carlos Gómez-Esteban; Iñigo Gabilondo
Journal:  Front Pharmacol       Date:  2019-10-30       Impact factor: 5.810

7.  Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans.

Authors:  Samuel Brennan; Matthew Keon; Bing Liu; Zheng Su; Nitin K Saksena
Journal:  Mol Neurobiol       Date:  2019-04-29       Impact factor: 5.590

8.  A comprehensive screening of copy number variability in dementia with Lewy bodies.

Authors:  Celia Kun-Rodrigues; Tatiana Orme; Susana Carmona; Dena G Hernandez; Owen A Ross; John D Eicher; Claire Shepherd; Laura Parkkinen; Lee Darwent; Michael G Heckman; Sonja W Scholz; Juan C Troncoso; Olga Pletnikova; Ted Dawson; Liana Rosenthal; Olaf Ansorge; Jordi Clarimon; Alberto Lleo; Estrella Morenas-Rodriguez; Lorraine Clark; Lawrence S Honig; Karen Marder; Afina Lemstra; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Janice Holton; Yaroslau Compta; Vivianna Van Deerlin; Geidy E Serrano; Thomas G Beach; Suzanne Lesage; Douglas Galasko; Eliezer Masliah; Isabel Santana; Pau Pastor; Monica Diez-Fairen; Miquel Aguilar; Pentti J Tienari; Liisa Myllykangas; Minna Oinas; Tamas Revesz; Andrew Lees; Brad F Boeve; Ronald C Petersen; Tanis J Ferman; Valentina Escott-Price; Neill Graff-Radford; Nigel J Cairns; John C Morris; Stuart Pickering-Brown; David Mann; Glenda M Halliday; John Hardy; John Q Trojanowski; Dennis W Dickson; Andrew Singleton; David J Stone; Rita Guerreiro; Jose Bras
Journal:  Neurobiol Aging       Date:  2018-10-24       Impact factor: 4.673

9.  A New Synuclein-Transgenic Mouse Model for Early Parkinson's Reveals Molecular Features of Preclinical Disease.

Authors:  Diana M Hendrickx; Pierre Garcia; Amer Ashrafi; Alessia Sciortino; Kristopher J Schmit; Heike Kollmus; Nathalie Nicot; Tony Kaoma; Laurent Vallar; Manuel Buttini; Enrico Glaab
Journal:  Mol Neurobiol       Date:  2020-09-30       Impact factor: 5.590

10.  Glutamate Transporter GLT1 Expression in Alzheimer Disease and Dementia With Lewy Bodies.

Authors:  Paula Garcia-Esparcia; Daniela Diaz-Lucena; Marina Ainciburu; Benjamin Torrejón-Escribano; Margarita Carmona; Franc Llorens; Isidro Ferrer
Journal:  Front Aging Neurosci       Date:  2018-04-26       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.